LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe

    06/03/2026

    PRESS RELEASE

    Brussels, 6 March 2026 – EuropaBio is pleased to welcome its newest member, Bene Meat Technologies (‘BeneMeat’).

    Founded in 2020, BeneMeat is pioneering a new generation of real animal meat production technology based on controlled cellular cultivation rather than traditional animal farming. As a biotech company within the BTL Group, since its establishment in 2020, BeneMeat has built end‑to‑end technological expertise across biology, chemistry, hardware, software, and commercial implementation. Today, its team of nearly 150 R&D specialists is developing the complete technological ecosystem required for cultivated meat production, from versatile cell line development to scalable, cost‑effective, and reliable manufacturing solutions. The company is prepared to support manufacturers through all the key challenges of bringing cultivated meat to market: technical, legal, regulatory, and commercial.

    By joining EuropaBio, BeneMeat aims to contribute practical regulatory expertise at a time when biotechnology policy is rapidly evolving, particularly ahead of the Biotech Act discussions on GMO classification and biotech market access.

    BeneMeat is the first in the EU to be registered as a producer of cultivated meat as raw material for pet food (Autumn 2023), proving the company’s regulatory leadership in this space. BeneMeat seeks to collaborate closely with EuropaBio’s Industrial Biotechnology Council to support evidence‑based policymaking that strengthens Europe’s competitiveness in breakthrough biotechnologies.

    Dr. Claire Skentelbery, Director General of EuropaBio, commented: “BeneMeat marks a step change for sustainability and resilience of supply chains for animal food in Europe. It is a fantastic testament to EU progression and innovation, and can only help to support animal health and a thriving nutritional sector.”

    Sergey Firulev, Business Development Partner at BeneMeat added: “Joining EuropaBio is a natural step for us. At BeneMeat, we are building a complete technological ecosystem for cultivated meat, from advanced cell line development to scalable manufacturing, and we bring hands-on regulatory experience within the European Union. We aim to actively contribute to expert discussions on the future of biotechnology in Europe, particularly regarding market access and the evolving legislative framework. We believe Europe has the potential to lead globally in breakthrough biotechnologies, provided that regulation remains science-based, predictable, and innovation-friendly. Our ambition is to be a constructive partner in shaping that environment.”

     

    ENDS

    About BeneMeat

    BeneMeat is a biotech company, part of the BTL Group, focused on developing scalable and efficient cultivated meat production technology. Since 2020, the company has developed deep, end-to-end expertise across biology, chemistry, hardware, software, and commercial implementation of cultivated meat. With 150+ R&D experts, BeneMeat is building the complete technological ecosystem, from versatile cell line development to scalable, reliable, and cost-effective manufacturing solutions. The company is prepared to support manufacturers through all the key challenges of bringing cultivated meat to market: technical, legal, regulatory, and commercial. BeneMeat is the first in the EU to be registered as a producer of cultivated meat for pet food (Autumn 2023), proving our regulatory leadership in this space. “We are not just another company in cultivated meat, we are the technology partner shaping its future.” www.benemeat.com

    Cultivated meat

    Cultivated meat, also known as cultured meat or cell-based meat, is real animal meat produced by directly growing animal cells in a controlled environment instead of raising and slaughtering animals. The process begins with a small sample of animal cells, which are nourished with essential nutrients and guided to form muscle, fat, and connective tissue, replicating natural biological growth. The result is meat that is biologically identical to conventional meat but can be produced more sustainably, with lower environmental impact and improved animal welfare. A term Cultivated meat refers to meat (including muscle cells, fat cells, connective tissue, blood, and other components) produced by cultivating animal cells, not by slaughtering a live animal. (Source: New Harvest – a research institute that aims to accelerate progress in cellular agriculture).

    Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe


    Download
    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    03/04/2026

    Pivot Bio joins EuropaBio: Advancing Innovation in Sustainable Agriculture


    Read more
    02/04/2026

    The EU Biotech Act II: A vital Act for biomanufacturing in Europe


    Read more
    31/03/2026

    Nestlé joins EuropaBio: Driving Innovation for Sustainable Food Systems


    Read more

    Important links

    • Pivot Bio joins EuropaBio: Advancing Innovation in Sustainable Agriculture
    • The EU Biotech Act II: A vital Act for biomanufacturing in Europe

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.